UNSPSC 51322404: Meglutol

This classification denotes an anticholesteremic agent, enzyme inhibitor, hydroxymethylglutaryl-coa reductase inhibitor, and hypolipidemic agent with the molecular formula C6H10O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CLA99KCD53, chemically known as pentanedioic acid, 3-hydroxy-3-methyl- but generally known as meglutol, which bears US NIH Compound Identifier 1662. European Medicines Agency schedules Meglutol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08716MIG.

UNSPSC 51322404 Meglutol, a Commodity code, encompasses emergency and specialty pharmaceuticals that state and local governments procure for emergency medical services, health benefit programs, and institutional healthcare delivery. Recent solicitations show that state and local buyers source specific branded and generic medications—including vasodilators, sympathomimetics, antiarrhythmics, and beta-blockers—through formal competitive bidding processes that require firm pricing, regulatory compliance documentation (Safety Data Sheets, FDA certifications, Good Manufacturing Practices), expiration-date warranties, and delivery commitments. Issuing bodies range from municipal fire and rescue departments to state health and human services agencies and multistate cooperative purchasing alliances. The City of Tampa's Purchasing Department and the Texas Health and Human Services Commission appear in recent activity, alongside the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which aggregates demand across participating state and local members. Solicitations emphasize small business set-asides where applicable and require vendors to meet accessibility and supply-chain security standards including Drug Supply Chain Security Act compliance.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with multistate cooperative vehicles such as MMCAP extending reach across regions. The City of Tampa issued an IFB (Bid No. 26P00188) due April 8, 2026, for Advanced Life Support Medications including Labetalol, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP (S1070000015802) with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities in Minnesota and Oregon, requiring vendor pricing through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson). The Texas Health and Human Services Commission posted an RFI (HHS0017013) on March 27, 2026 seeking market intelligence on direct-to-manufacturer prescription programs, signaling potential future formal procurement as the agency develops strategy for pharmacy benefit management outside traditional wholesaler and GPO channels.